Emergent BioSolutions (EBS) PT Raised to $145 at Argus
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.61 +2.44%
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
Argus analyst Jasper Hellweg raised the price target on Emergent BioSolutions (NYSE: EBS) to $145.00 (from $90.00) while maintaining a Buy rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- CrowdStrike (CRWD) PT Raised to $250 at Benchmark Ahead of Q2 Results
- Gartner (IT) PT Lowered to $206 at BMO Capital, adjusting estimates
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
